Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Etamicastat；BIA 5-453 | C14H15F2N3OS | 760173-05-5 | Details |
| EMDT oxalate | C15H22N2O | 263744-72-5 | Details |
| ent-Ezetimibe | C24H21F2NO3 | 1376614-99-1 | Details |
| eIF4A3-IN-2 | C25H19Br2ClN4O2 | 2095677-20-4 | Details |
| Ethyl glucuronide | C8H14O7 | 17685-04-0 | Details |
| EML741 | C31H49N5O2 | 2328074-38-8 | Details |
| Podofilox | C22H22O8 | 518-28-5 | Details |
| Erythromycin thiocyanate | C38H68N2O13S | 7704-67-8 | Details |
| Endoxifen (E-isomer) | C25H27NO2 | 114828-90-9 | Details |
| ERB-196；WAY-202196 | C17H10FNO2 | 550997-55-2 | Details |
| Equisetin | C22H31NO4 | 57749-43-6 | Details |
| Estradiol 3-sulfamate | C18H25NO4S | 172377-52-5 | Details |
| Rineterkib | C26H27BrF3N5O2 | 1715025-32-3 | Details |
| Epertinib hydrochloride；S-22611 hydrochloride | C30H28Cl2FN5O3 | 2071195-74-7 | Details |
| Evogliptin tartrate；DA-1229 tartrate | C19H26F3N3O3 · (C4H6O6) | 1222102-51-3 | Details |
| Enalapril D5 maleate；MK-421 D5 maleate | C24H27D5N2O9 | 349554-02-5 | Details |
| Shikonin；Isoarnebin 4;Anchusa acid;NSC 252844;Alkanna Red;(+)-Shikonin;C.I. 75535 | C16H16O5 | 517-89-5 | Details |
| Emtricitabine S-oxide；Emtricitabine sulfoxide;Emtricitabine Degradant-III | C8H10FN3O4S | 152128-77-3 | Details |
| EMD638683 S-Form | C18H18F2N2O4 | 1184940-46-2 | Details |
| Episilvestrol | C34H38O13 | 697235-39-5 | Details |
| Flumethasone | C22H28F2O5 | 2135-17-3 | Details |
| Camptothecin；CPT;NSC-100880;(S)-(+)-Camptothecin;Campathecin | C20H16N2O4 | 7689-03-4 | Details |
| Rasagiline | C12H13N | 136236-51-6 | Details |
| Endomorphin 2 TFA | C34H38F3N5O7 | 1276124-00-5 | Details |
| Cefprozil monohydrate | C18H21N3O6S | 121123-17-9 | Details |
| Giredestrant tartrate | C31H37F5N4O7 | 2407529-33-1 | Details |
| EMPA | C23H26N4O4S | 680590-49-2 | Details |
| Etamicastat hydrochloride | C14H16ClF2N3OS | 677773-32-9 | Details |
| EOAI3402143 | C25H28Cl2N4O3 | 1699750-95-2 | Details |
| Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
| EP1013；F1013 | C18H23FN2O6 | 223568-55-6 | Details |
| Etravirine D4；TMC-125 D4;R-165335 D4 | C20H11BrD4N6O | 1142095-93-9 | Details |
| ELN318463 racemate | C19H20BrClN2O3S | 851599-82-1 | Details |
| p38 MAPK-IN-2 | C20H19ClFN5O2 | 635725-16-5 | Details |
| Eravacycline dihydrochloride；TP-434-046;TP-434 dihydrochloride | C27H32ClFN4O8 | 1334714-66-7 | Details |
| eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
| Elubrixin | C17H17Cl2FN4O4S | 688763-64-6 | Details |
| Enocyanin | C15H11O+ | 11029-12-2 | Details |
| (R)-Elagolix | C32H30F5N3O5 | 834153-87-6 | Details |
| EMD638683 R-Form | C18H18F2N2O4 | 1184940-47-3 | Details |
| Camizestrant | C24H28F4N6 | 2222844-89-3 | Details |
| Elinogrel；PRT060128 | C20H15ClFN5O5S2 | 936500-94-6 | Details |
| Ethacrynic acid D5 | C13H12Cl2O4 | 1330052-59-9 | Details |
| Enzalutamide-d3；Enzalutamide D3;MDV3100 D3 | C21H13D3F4N4O2S | 1443331-82-5 | Details |
| Etoricoxib-d4；MK-0663 D4;Etoricoxib D4;L-791456 D4 | C18H11ClD4N2O2S | 1131345-14-6 | Details |
| EHMT2-IN-2 | C21H22N6O | 2230850-47-0 | Details |
| EPI-589 | C14H19NO4 | 1147883-03-1 | Details |
| Ezetimibe ketone；EZM-K | C24H19F2NO3 | 191330-56-0 | Details |
| EHNA hydrochloride | C14H24ClN5O | 58337-38-5 | Details |
| ent-Tadalafil；ent-IC-351 | C22H19N3O4 | 629652-72-8 | Details |
| Entacapone sodium salt | C14H14N3NaO5 | 1047659-02-8 | Details |
| Emixustat；ACU-4429 | C16H25NO2 | 1141777-14-1 | Details |
| ENS-163 phosphate；Sandoz ENS 163 phosphate;Thiopilocarpine phosphate;ENS 213-163 | C11H19N2O5PS | 117707-51-4 | Details |
| Dxd | C26H24FN3O6 | 1599440-33-1 | Details |
| Ethyl tosylcarbamate | C10H13NO4S | 5577-13-9 | Details |
| Dacarbazine | C6H10N6O | 4342-03-4 | Details |
| Etiracetam；UCB 6474 | C8H14N2O2 | 33996-58-6 | Details |
| Emixustat hydrochloride；ACU-4429 hydrochloride | C16H26ClNO2 | 1141934-97-5 | Details |
| Eriosematin | C19H20O4 | 168010-17-1 | Details |
| Epertinib；S-22611 | C30H27ClFN5O3 | 908305-13-5 | Details |
| Eplivanserin (mixture)；SR-46349 (mixture);Eplivanserin mixture | C19H21FN2O2 | 130581-13-4 | Details |
| EN6 | C19H14F2N4O2 | 1808714-73-9 | Details |
| ERK1/2 inhibitor 1 | C29H32ClN5O4 | 2095719-90-5 | Details |
| EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
| Exatecan | C24H22FN3O4 | 171335-80-1 | Details |
| Eravacycline；TP-434 | C27H31FN4O8 | 1207283-85-9 | Details |
| EMT inhibitor-1 | C12H12Cl2N2O2S | 1638526-21-2 | Details |
| Cephalothin sodium | C16H16N2O6S2.Na | 58-71-9 | Details |
| EIPA hydrochloride；L593754 hydrochloride;MH 12-43 hydrochloride | C11H19Cl2N7O | 1345839-28-2 | Details |
| ERAP1-IN-1 | C20H21F3N2O5S | 865273-97-8 | Details |
| Embramine | C18H22BrNO | 3565-72-8 | Details |
| EML4-ALK kinase inhibitor 1 | C31H48N8O3 | 1373409-08-5 | Details |
| Ezetimibe-d4；SCH 58235 D4;Ezetimibe D4 | C24H17D4F2NO3 | 1093659-90-5 | Details |
| EP4 receptor antagonist 1 | C23H21F3N4O3 | 2287259-07-6 | Details |
| Ezetimibe phenoxy glucuronide；Ezetimibe β-D-glucuronide;Ezetimibe glucuronide | C30H29F2NO9 | 190448-57-8 | Details |
| ELN318463；ELN 318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
| Eplivanserin | C19H21FN2O2 | 130579-75-8 | Details |
| Enniatin A1 | C35H61N3O9 | 4530-21-6 | Details |
| Elenbecestat | C19H18F3N5O2S | 1388651-30-6 | Details |
| Enalaprilat D5；MK-422 D5 | C18H19D5N2O5 | 349554-00-3 | Details |
| F-1 | C22H27ClN8O3S | 2244775-31-1 | Details |
| Eicosatetraynoic acid；ETYA | C20H24O2 | 1191-85-1 | Details |
| ε-Viniferin | C28H22O6 | 62218-08-0 | Details |
| Enalaprilat-d5 sodium；Enalaprilat D5 Sodium Salt;MK-422 D5 Sodium Salt | C18H18D5N2NaO5 | 1356922-29-6 | Details |
| ER21355 | C22H21ClN4O4 | 150452-18-9 | Details |
| Ezetimibe phenoxy glucuronide-D4；Ezetimibe glucuronide-D4;Ezetimibe β-D-glucuronide-D4 | C30H25D4F2NO9 | 1426174-41-5 | Details |
| Enazadrem | C18H25N3O | 107361-33-1 | Details |
| Etimizol | C9H14N4O2 | 64-99-3 | Details |
| EPAC 5376753 | C15H8Cl2N2O3S | 302826-61-5 | Details |
| FAAH-IN-1 | C20H19ClN4OS | 1242441-47-9 | Details |
| Erysotrine | C19H23NO3 | 27740-43-8 | Details |
| ERK2 IN-1 | C36H34FN7O2S | 1093061-47-2 | Details |
| Ethacizine hydrochloride | C22H28ClN3O3S | 57530-40-2 | Details |
| FAAH inhibitor 1 | C24H23N3O3S3 | 326866-17-5 | Details |
| Eliglustat hemitartrate | C50H78N4O14 | 928659-70-5 | Details |
| ESI-08 | C20H23N3OS | 301177-43-5 | Details |
| Enniatin complex | C36H63N3O9.C35H61N3O9.C34H59N3O9.C33H57N3O9 | 11113-62-5 | Details |
| Clorgyline hydrochloride | C13H16Cl3NO | 17780-75-5 | Details |
| Erlotinib-d6；NSC 718781 D6;OSI-774 D6;Erlotinib D6;CP-358774 D6 | C22H23N3O4 | 1034651-23-4 | Details |
| ERRα antagonist-1 | C21H19N3S2 | 1072145-33-5 | Details |
| Product Total： Product Page： | ||||
| 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 | ||||